These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 25541526

  • 1. Molecular recognition of CYP26A1 binding pockets and structure-activity relationship studies for design of potent and selective retinoic acid metabolism blocking agents.
    Sun B, Song S, Hao CZ, Huang WX, Liu CC, Xie HL, Lin B, Cheng MS, Zhao DM.
    J Mol Graph Model; 2015 Mar; 56():10-9. PubMed ID: 25541526
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis, and biological evaluation of amide imidazole derivatives as novel metabolic enzyme CYP26A1 inhibitors.
    Sun B, Liu K, Han J, Zhao LY, Su X, Lin B, Zhao DM, Cheng MS.
    Bioorg Med Chem; 2015 Oct 15; 23(20):6763-73. PubMed ID: 26365710
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and CYP26A1 inhibitory activity of novel methyl 3-[4-(arylamino)phenyl]-3-(azole)-2,2-dimethylpropanoates.
    Gomaa MS, Lim AS, Lau SC, Watts AM, Illingworth NA, Bridgens CE, Veal GJ, Redfern CP, Brancale A, Armstrong JL, Simons C.
    Bioorg Med Chem; 2012 Oct 15; 20(20):6080-8. PubMed ID: 22989911
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Structural basis for cooperative binding of azoles to CYP2E1 as interpreted through guided molecular dynamics simulations.
    Levy JW, Hartman JH, Perry MD, Miller GP.
    J Mol Graph Model; 2015 Mar 15; 56():43-52. PubMed ID: 25544389
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1.
    Foti RS, Isoherranen N, Zelter A, Dickmann LJ, Buttrick BR, Diaz P, Douguet D.
    J Pharmacol Exp Ther; 2016 May 15; 357(2):281-92. PubMed ID: 26937021
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Substrate specificity and ligand interactions of CYP26A1, the human liver retinoic acid hydroxylase.
    Thatcher JE, Buttrick B, Shaffer SA, Shimshoni JA, Goodlett DR, Nelson WL, Isoherranen N.
    Mol Pharmacol; 2011 Aug 15; 80(2):228-39. PubMed ID: 21521770
    [Abstract] [Full Text] [Related]

  • 12. Homology Models and Molecular Modeling of Human Retinoic Acid Metabolizing Enzymes Cytochrome P450 26A1 (CYP26A1) and P450 26B1 (CYP26B1).
    Karlsson M, Strid Å, Sirsjö A, Eriksson LA.
    J Chem Theory Comput; 2008 Jun 15; 4(6):1021-7. PubMed ID: 26621242
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells.
    Ozpolat B, Mehta K, Lopez-Berestein G.
    Leuk Lymphoma; 2005 Oct 15; 46(10):1497-506. PubMed ID: 16194896
    [Abstract] [Full Text] [Related]

  • 17. Effect of NADPH-cytochrome P450 reductase on all-trans-retinoic acid efficacy and cytochrome P450 26A1 expression in human myeloid leukaemia HL-60 cells.
    Hu L, Lv JF, Zhuo W, Zhang CM, Zhou HH, Fan L.
    J Pharm Pharmacol; 2016 Sep 15; 68(9):1193-202. PubMed ID: 27366899
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.